Compare COHN & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COHN | DRIO |
|---|---|---|
| Founded | 1999 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.3M | 60.6M |
| IPO Year | 2003 | 2013 |
| Metric | COHN | DRIO |
|---|---|---|
| Price | $11.08 | $8.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | ★ 39.9K | 6.0K |
| Earning Date | 05-01-2026 | 05-14-2026 |
| Dividend Yield | ★ 4.35% | N/A |
| EPS Growth | ★ 5537.50 | 1559.02 |
| EPS | 0.42 | ★ 1.25 |
| Revenue | ★ $275,564,000.00 | $7,394,000.00 |
| Revenue This Year | N/A | $20.27 |
| Revenue Next Year | N/A | $47.58 |
| P/E Ratio | $25.95 | ★ $6.04 |
| Revenue Growth | ★ 246.19 | 43.02 |
| 52 Week Low | $7.78 | $0.38 |
| 52 Week High | $32.60 | $17.74 |
| Indicator | COHN | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 34.38 | 48.37 |
| Support Level | $10.89 | $7.29 |
| Resistance Level | $12.79 | $9.46 |
| Average True Range (ATR) | 1.12 | 0.46 |
| MACD | -0.38 | -0.01 |
| Stochastic Oscillator | 19.13 | 37.89 |
Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.